Add to balance / Manage account | Not logged in |
Prospect News home > Main news index > All issuers starting with M > All stories on MolecularMD, Inc. |
6/26/2006 | BT | ChemGenex, MolecularMD to identify leukemia patients with T315I mutation for phase 2/ 3 trial |